Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianer Qingjie Oral Liquid is a Traditional Chinese Medicine (TCM) product developed and manufactured by Jiangxi Wannianqing Pharmaceutical. It is specifically formulated for pediatric use to address symptoms of upper respiratory tract infections and associated digestive issues. The preparation typically includes a blend of herbal ingredients such as Lonicera japonica (Honeysuckle), Forsythia suspensa, Chrysanthemum, and Crataegus (Hawthorn). Its primary therapeutic actions involve clearing heat, detoxifying the body, and promoting digestion to relieve symptoms like fever, cough, sore throat, and loss of appetite. It is widely used in China and is an approved pharmaceutical product for the pediatric population.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianer Qingjie Oral Liquid.